Abstract
Purpose
Critically ill patients, among whom acute kidney injury is common, are often considered particularly vulnerable to iodinated contrast medium nephrotoxicity. However, the attributable incidence remains uncertain given the paucity of observational studies including a control group. This study assessed acute kidney injury incidence attributable to iodinated contrast media in critically ill patients based on new data accounting for sample and effect size and including a control group.
Methods
Systematic review of studies measuring incidence of acute kidney injury in critically ill patients following contrast medium exposure compared to matched unexposed patients. Patient-level meta-analysis implementing a Bayesian nested mixed effects multiple logistic regression model.
Results
Ten studies were identified; only four took into account the baseline acute kidney injury risk, three by patient matching (560 patients). Objective meta-analysis of these three studies (vague and impartial a priori hypothesis concerning attributable acute kidney injury risk) did not find that iodinated contrast media increased the incidence of acute kidney injury (odds ratio 0.95, 95% highest posterior density interval 0.45–1.62). Bayesian analysis demonstrated that, to conclude in favor of a statistically significant incidence of acute kidney injury attributable to contrast media despite this observed lack of association, one’s a priori belief would have to be very strongly biased, assigning to previous uncontrolled reports 3–12 times the weight of evidence strength provided by the matched studies including a control group.
Conclusions
Meta-analysis of matched cohort studies of iodinated contrast medium exposure does not support a significant incidence of acute kidney injury attributable to iodinated contrast media in critically ill patients.
Similar content being viewed by others
References
Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2:S1–S138. doi:10.1038/kisup.2012.1
Brochard L, Abroug F, Brenner M, Broccard AF, Danner RL, Ferrer M, Laghi F, Magder S, Papazian L, Pelosi P, Polderman KH, ATS, ERS, ESICM, SCCM, SRLF Ad Hoc Committee on Acute Renal Failure (2010) An Official ATS/ERS/ESICM/SCCM/SRLF statement: prevention and management of acute renal failure in the ICU patient: an international consensus conference in intensive care medicine. Am J Respir Crit Care Med 181:1128–1155. doi:10.1164/rccm.200711-1664ST
Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG, Sprayregen S (1991) Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol 157:49–58. doi:10.2214/ajr.157.1.2048539
Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G (2004) A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399. doi:10.1016/j.jacc.2004.06.068
Brown JR, DeVries JT, Piper WD, Robb JF, Hearne MJ, Ver Lee PM, Kellet MA, Watkins MW, Ryan TJ, Silver MT, Ross CS, MacKenzie TA, O’Connor GT, Malenka DJ, Northern New England Cardiovascular Disease Study Group (2008) Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J 155:260–266. doi:10.1016/j.ahj.2007.10.007
McDonald JS, McDonald RJ, Comin J, Williamson EE, Katzberg RW, Murad MH, Kallmes DF (2013) Frequency of acute kidney injury following intravenous contrast medium administration: a systematic review and meta-analysis. Radiology 267:119–128. doi:10.1148/radiol.12121460
McDonald JS, McDonald RJ, Carter RE, Katzberg RW, Kallmes DF, Williamson EE (2014) Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology 271:65–73. doi:10.1148/radiol.13130775
McDonald RJ, McDonald JS, Carter RE, Hartman RP, Katzberg RW, Kallmes DF, Williamson EE (2014) Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology 273:714–725. doi:10.1148/radiol.14132418
Rashid AH, Brieva JL, Stokes B (2009) Incidence of contrast-induced nephropathy in intensive care patients undergoing computerized tomography and prevalence of risk factors. Anaesth Intensive Care 37:968–975
Hoste EA, Doom S, De Waele J, Delrue LJ, Defreyne L, Benoit DD, Decruyenaere J (2011) Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med 37:1921–1931. doi:10.1007/s00134-011-2389-8
Lakhal K, Ehrmann S, Chaari A, Laissy JP, Régnier B, Wolff M, Pajot O (2011) Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: incidence and outcome. J Crit Care 26:593–599. doi:10.1016/j.jcrc.2011.05.010
Persson PB, Hansell P, Liss P (2005) Pathophysiology of contrast medium-induced nephropathy. Kidney Int 68:14–22. doi:10.1038/sj.ki.5001887
Andreucci M, Solomon R, Tasanarong A (2014) Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention. Biomed Res Int 214:741018. doi:10.1155/2014/741018
Fernandes SM, Martins DM, da Fonseca CD, Watanabe M, de Vattimo MF (2016) Impact of iodinated contrast on renal function and hemodynamics in rats with chronic hyperglycemia and chronic kidney disease. Biomed Res Int 2016:3019410. doi:10.1155/2016/3019410
Rouse RL, Stewart SR, Thompson KL, Zhang J (2013) Kidney injury biomarkers in hypertensive, diabetic, and nephropathy rat models treated with contrast media. Toxicol Pathol 41:662–680. doi:10.1177/0192623312464122
Heyman SN, Rosen S, Rosenberger C (2008) Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 3:288–296. doi:10.2215/CJN.02600607
Vandenberghe W, De Corte W, Hoste EA (2014) Contrast-associated AKI in the critically ill: relevant or irrelevant? Curr Opin Crit Care 20:596–605. doi:10.1097/MCC.0000000000000156
Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, Tierney JF, PRISMA-IPD Development Group (2015) Preferred reporting items for a systematic review and meta-analysis of individual participant data. The PRISMA-IPD statement. JAMA 313:1657–1665. doi:10.1001/jama.2015.3656
Schardt C, Adams MB, Owens T, Keitz S, Fontelo P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inform Decis Mak 7:16. doi:10.1186/1472-6947-7-16
Ruppert D, Wand MP, Carroll RJ (2003) Semiparametric regression. Cambridge University Press, New York
Hobbs BP, Thall PF, Lin SH (2016) Bayesian Group sequential clinical trial design using total toxicity burden and progression-free survival. J R Stat Soc Ser C Appl Stat 65:273–297. doi:10.1111/rssc.12117
Spiegelhalter DJ, Abrams KR, Myles JP (2003) Evidence synthesis. In: Spiegelhalter DJ, Abrams KR, Myles JP (eds) Bayesian approaches to clinical trials and health-care evaluation. Wiley, Chichester, pp 267–299
Morita S, Thall PF, Müller P (2008) Determining the effective sample size of a parametric prior. Biometrics 64:595–602. doi:10.1111/j.1541-0420.2007.00888.x
Huber W, Jeschke B, Page M, Weiss W, Salmhofer H, Schweigart U, Ilgmann K, Reichenberger J, Neu B, Classen M (2001) Reduced incidence of radiocontrast-induced nephropathy in ICU patients under theophylline prophylaxis: a prospective comparison to series of patients at similar risk. Intensive Care Med 27:1200–1209
Haveman JW, Gansevoort RT, Bongaerts AH, Nijsten MW (2006) Low incidence of nephropathy in surgical ICU patients receiving intravenous contrast: a retrospective analysis. Intensive Care Med 32:1199–1205. doi:10.1007/s00134-006-0198-2
Polena S, Yang S, Alam R, Gricius J, Gupta JR, Badalova N, Chuang P, Gintautas J, Conetta R (2005) Nephropathy in critically ill patients without preexisting renal disease. Proc West Pharmacol Soc 48:134–135
Tremblay LN, Tien H, Hamilton P, Brenneman FD, Rizoli SB, Sharkey PW, Chu P, Rozycki GS (2005) Risk and benefit of intravenous contrast in trauma patients with an elevated serum creatinine. J Trauma 59:1162–1166
Oleinik A, Romero JM, Schwab K, Lev MH, Jhawar N, Delgado Almandoz JE, Smith EE, Greenberg SM, Rosand J, Goldstein JN (2009) CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke 40:2393–2397. doi:10.1161/STROKEAHA.108.546127
McGillicuddy EA, Schuster KM, Kaplan LJ, Maung AA, Lui FY, Maerz LL, Johnson DC, Davis KA (2010) Contrast-induced nephropathy in elderly trauma patients. J Trauma 68:294–297. doi:10.1097/TA.0b013e3181cf7e40
Ng CS, Shaw AD, Bell CS, Samuels JA (2010) Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU. AJR Am J Roentgenol 195:414–422. doi:10.2214/AJR.09.4150
Cely CM, Schein RM, Quartin AA (2012) Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study. Crit Care 16:R67. doi:10.1186/cc11317
Kim DY, Kobayashi L, Costantini TW, Chang D, Fortlage D, Curry T, Wynn S, Doucet J, Bansal V, Coimbra R (2012) Is contrast exposure safe among the highest risk trauma patients? J Trauma Acute Care Surg 72:61–66. doi:10.1097/TA.0b013e31823f36e0
Ehrmann S, Badin J, Savath L, Pajot O, Garot D, Pham T, Capdevila X, Perrotin D, Lakhal K (2013) Acute kidney injury in the critically ill: is iodinated contrast medium really harmful? Crit Care Med 41:1017–1026. doi:10.1097/CCM.0b013e318275871a
Christ M, Auenmüller KI, Amirie S, Brand M, Sasko BM, Trappe HJ (2016) Acute kidney injury and renal replacement therapy in victims from out-of-hospital cardiac arrest with administration of contrast agent. Herzschrittmarcherther Elektrophysiol 27:6–14. doi:10.1007/s00399-015-0410-6
Gao J, Zhang M, Fang G, Ye L, Tang W (2005) Risk and harm of contrast induced nephropathy in critically ill patients. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 27:366–370. doi:10.3760/cma.j.issn.2095-4352.2015.05.009
Wilhelm-Leen E, Montez-Rath ME, Chertow G (2016) Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol 28. doi:10.1681/ASN.2016010021
Subramaniam RM, Suarez-Cuervo C, Wilson RF, Turban S, Zhang A, Sherrod C, Aboagye J, Eng J, Choi MJ, Hutfless S, Bass EB (2016) Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 164:406–416. doi:10.7326/M15-1456
Eng J, Wilson RF, Subramaniam RM, Zhang A, Suarez-Cuervo C, Turban S, Choi MJ, Sherrod C, Hutfless S, Lyoha EE, Bass EB (2016) Comparative effect of contrast media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis. Ann Intern Med 164:417–424. doi:10.7326/M15-1402
Salmon-Gandonnière C, Benz-de-Bretagne I, Mercier E, Joret A, Halimi JM, Ehrmann S, Barin-Le Guellec C (2016) Iohexol clearance in unstable critically ill patients: a tool to assess glomerular filtration rate. Clin Chem Lab Med 54:1777–1786. doi:10.1515/cclm-2015-1202
Bihorac A, Chawla LS, Shaw AD, Al-Khafaji A, Davison DL, Demuth GE, Gitzgerald R, Gong MN, Graham DD, Gunnerson K, Heung M, Jortani S, Kleerup E, Koyner JL, Krell K, Letourneau J, Lissauer M, Miner J, Nguyen HB, Ortega LM, Self WH, Sellman R, Shi J, Straseski J, Szalados JE, Wilber ST, Walker MG, Wilson J, Wunderink R, Zimmerman J, Kellum JA (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189:932–999. doi:10.1164/rccm.201401-0077OC
Acknowledgements
The authors acknowledge the following grant support: Cancer Center Support Grant and National Institute for health/National Cancer Institute grant P30CA016672.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Additional information
Take-home message: This Bayesian meta-analysis of matched cohort studies of iodinated contrast medium exposure does not support a significant association with acute kidney injury incidence in critically ill patients. The continued belief that critically ill patients are particularly vulnerable to iodinated contrast medium nephrotoxicity rests on heavily weighting evidence from studies without a control group.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ehrmann, S., Quartin, A., Hobbs, B.P. et al. Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med 43, 785–794 (2017). https://doi.org/10.1007/s00134-017-4700-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-017-4700-9